Search Results - "Gane, Ed J"

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection by Zeuzem, Stefan, Soriano, Vincent, Asselah, Tarik, Bronowicki, Jean-Pierre, Lohse, Ansgar W, Müllhaupt, Beat, Schuchmann, Marcus, Bourlière, Marc, Buti, Maria, Roberts, Stuart K, Gane, Ed J, Stern, Jerry O, Vinisko, Richard, Kukolj, George, Gallivan, John-Paul, Böcher, Wulf-Otto, Mensa, Federico J

“…In this phase 2b study, an interferon-free regimen consisting of the combination of a protease inhibitor (faldaprevir), a nonnucleoside polymerase inhibitor…”
Get full text

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection by Gane, Ed J., Schwabe, Christian, Berliba, Elina, Tangkijvanich, Pisit, Jucov, Alina, Ghicavii, Nelea, Verbinnen, Thierry, Lenz, Oliver, Talloen, Willem, Kakuda, Thomas N., Westland, Chris, Patel, Megha, Yogaratnam, Jeysen Z., Dragone, Leonard, Van Remoortere, Pieter

“…Abstract Objectives We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients…”
Get full text

S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study by Janssen, Harry, Heo, Jeong, Fournier, Claire, Ahn, Sang Hoon, Coffin, Carla S., 黃, 怡翔, Hui, Aric Josun, Elkhashab, Magdy, Jafri, Syed-Mohammed, Mo, Shuyuan, Winans, Jake, Flaherty, John, Gaggar, Anuj, Chuang, Wan-Long, Gane, Ed J., Lim, Young-Suk

Get full text

Faldaprevir and Deleobuvir for HCV Genotype 1 Infection by ZEUZEM, Stefan, SORIANO, Vincent, GANE, Ed J, STERN, Jerry O, VINISKO, Richard, KUKOLJ, George, GALLIVAN, John-Paul, BÖCHER, Wulf-Otto, MENSA, Federico J, ASSELAH, Tarik, BRONOWICKI, Jean-Pierre, LOHSE, Ansgar W, MÜLLHAUPT, Beat, SCHUCHMANN, Marcus, BOURLIERE, Marc, BUTI, Maria, ROBERTS, Stuart K

Get full text

Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation by Vasudevan, Abhinav, Ardalan, Zaid S, Ahmed, Navera, Apostolov, Ross, Gow, Paul J, Testro, Adam G, Gane, Ed J, Angus, Peter W

“…Limitations to the use of long-term Hepatitis B Immunoglobulin (HBIg) following liver transplantation for hepatitis B (HBV) have led to the substitution of…”
Get full text

W1814 Safety and Tolerability of 96 Weeks of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg Negative and Positive Patients Infected with Chronic Hepatitis B (CHB) by Jacobson, Ira M, Marcellin, Patrick, Heathcote, Jenny, Mathurin, Philippe, Gane, Ed J, Buggisch, Peter, Husa, Petr, Krastev, Zahary, Sorbel, Jeff, Anderson, Jane, Mondou, Elsa, Rousseau, Franck

Get full text

M1913 Lack of Influence of Baseline Genotype On Antiviral Response in Subjects with Chronic Hepatitis B Infection Receiving Tenofovir Df 300 Mg Qd for 1 Year by Younossi, Zobair M, Benhamou, Yves, Gane, Ed J, Zeuzem, Stefan, Heathcote, Jenny, Marcellin, Patrick, Sorbel, Jeff, Borroto-Esoda, Katyna, Rousseau, Franck, Snow-Lampart, Andrea

Get full text